Pharmaceutical manufacturinq effluent limitations
The Environmental Protection Agency announced that based on new information concerning the possible harmful effects of discharges containing methylene chloride it may reconsider decision not to establish regulations controlling the discharge of volatile priority pollutants. EPA said it is reviewing and updating data for technologies capable of removing methylene chloride and other volatile priority pollutants from pharmaceutical plants.
You may also be interested in...
Valneva is scaling up manufacture of its coronavirus vaccine alongside the clinical development program, with a view to meeting its commitment to provide millions of doses for use in the UK and the EU.
The UK government says it will begin a consultation on a future falsified medicines scheme for Great Britain within a year after the passage of new legislation on medicines and medical devices. Moves are also under way to ensure the smooth supply of medicines from GB to Cyprus, Ireland, Malta and Northern Ireland.
The sentences are the latest chapter in a long-running off-label marketing case.